Dr. Regina Hodits

Venture Advisor

  • PhD in biochemistry
  • Joined Wellington in 2010
  • Former Partner at Atlas, Investment Manager at Apax and Consultant at McKinsey & Co.
  • More than 25 investments and successful exits incl. Themis, Rigontec, Sapiens Medical, Middle Peak Medical, and Bicycle Therapeutics
  • Transition from Managing Partner to Venture Advisor in 2025
CONTACTEMAILLINKEDIN

Knowing is not enough; we must apply. Willing is not enough; we must do.

— Johann Wolfgang von Goethe

Biography

Regina was a Managing Partner at Wellington Partners until 2025. During her tenure she was responsible for more than 25 investments, thereof 13 out of our WPLS-III, WPLS-IV and WPLS-V funds, five of which have already been realized via successful acquisitions i.e. Themis by MSD in 2020, Rigontec by MSD in 2017, Middle Peak Medical by Symetis in 2017, Atopix Therapeutics by Chiesi in 2016, Sapiens by Medtronic in 2014, and Onward IPOed on Euronext.

She represented the WPLS funds on the Boards of Carisma, ONWARD, Sidekick, SNIPR Biome and Stipe, is a member of the Advisory Council of KfW Capital, and served as the Spokesperson for the Board of the German PE and VC Association (BVK) from 2015 to 2020. Since joining the industry in 2000, she has become an influential investor in the European VC industry, focusing on early-stage and growth deals in the life science sector.

In 2025, Regina transitioned to a Venture Advisor role with Wellington Partners. In her new role, she continues to support the existing portfolio. Wellington Partners is very grateful for her commitment during her tenure with the firm.

Cases

Full Team